JANE STREET GROUP, LLC - TAKEDA PHARMACEUTICAL CO LTD ownership

TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 310 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q3 2020. The put-call ratio across all filers is 1.22 and the average weighting 0.2%.

Quarter-by-quarter ownership
JANE STREET GROUP, LLC ownership history of TAKEDA PHARMACEUTICAL CO LTD
ValueSharesWeighting
Q2 2024$7,813,121
+23.4%
603,796
+32.5%
0.00%
+100.0%
Q1 2024$6,330,256
-61.1%
455,742
-60.0%
0.00%
-75.0%
Q4 2023$16,265,360
+156.1%
1,139,829
+177.7%
0.00%
+100.0%
Q3 2023$6,350,729
-59.5%
410,519
-58.8%
0.00%
-60.0%
Q2 2023$15,665,839
+1609.3%
997,189
+1693.1%
0.01%
Q1 2023$916,486
-82.9%
55,612
-86.5%
0.00%
-100.0%
Q3 2022$5,371,000
-36.1%
412,869
-30.9%
0.00%
-50.0%
Q2 2022$8,400,000
+195.0%
597,343
+201.5%
0.00%
+300.0%
Q1 2022$2,847,000
-80.7%
198,100
-81.7%
0.00%
-75.0%
Q4 2021$14,743,000
-39.9%
1,081,736
-26.7%
0.00%
-50.0%
Q3 2021$24,517,000
+593.0%
1,475,019
+597.6%
0.01%
+300.0%
Q2 2021$3,538,000
-53.0%
211,445
-49.4%
0.00%
-50.0%
Q1 2021$7,526,000
+129.9%
418,162
+132.2%
0.00%
+300.0%
Q4 2020$3,273,000
+171.2%
180,068
+164.9%
0.00%0.0%
Q3 2020$1,207,000
-71.2%
67,982
-71.1%
0.00%
-66.7%
Q2 2020$4,189,000
+71.0%
235,037
+47.6%
0.00%
+50.0%
Q1 2020$2,449,000
+48.3%
159,194
+92.2%
0.00%0.0%
Q4 2019$1,651,000
-45.1%
82,830
-53.0%
0.00%
-60.0%
Q3 2019$3,006,000
+518.5%
176,102
+542.1%
0.01%
+400.0%
Q2 2019$486,000
-89.3%
27,427
-87.7%
0.00%
-85.7%
Q1 2019$4,531,000
-66.5%
222,111
-72.3%
0.01%
-75.9%
Q4 2018$13,544,000801,3030.03%
Other shareholders
TAKEDA PHARMACEUTICAL CO LTD shareholders Q3 2020
NameSharesValueWeighting ↓
Adelphi Capital LLP 9,270,535$188,841,00039.13%
Sachem Head Capital 5,963,600$121,479,0007.38%
NINE MASTS CAPITAL Ltd 1,049,886$21,415,0006.68%
Paulson & Co. 26,489,422$539,590,0005.77%
Blackcrane Capital, LLC 189,549$3,861,0005.16%
Glenview Capital Management 26,112,660$531,915,0004.75%
Exane Asset Management 430,369$8,766,617,0004.26%
Velanne Asset Management Ltd 281,972$5,744,0003.97%
Bluefin Trading, LLC 1,204,702$24,540,0003.55%
Endurant Capital Management LP 437,436$8,911,0003.52%
View complete list of TAKEDA PHARMACEUTICAL CO LTD shareholders